Connecting the dots; Anti-PL7 Antisynthetase Syndrome, Infliximab, and Granulomas — A Case Report
This case report describes a 72-year-old man with anti-PL7 antisynthetase syndrome who developed disseminated histoplasmosis due to the reactivation of a latent infection decades after initial exposure following a switch to infliximab therapy, highlighting the critical need to consider fungal reactivation in immunocompromised patients presenting with new granulomatous lung disease even when initial microbiological tests are negative.